Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Ribe Dentallaboratorium ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   2.2% 2.2% 2.2% 2.2% 2.2% 2.2% 2.2% 2.2%   Bankruptcy risk   1.9% 1.7% 1.2% 0.9% 1.5% 2.0% 16.9% 16.6%   Credit score (0-100)   71 75 81 88 76 68 10 11   Credit rating   A A A A A A BB BB   Credit limit (kDKK)   0.4 2.6 47.4 191.8 10.4 0.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,877 3,936 3,956 3,677 3,471 3,362 0.0 0.0   EBITDA   465 452 662 705 462 402 0.0 0.0   EBIT   140 126 329 515 437 393 0.0 0.0   Pre-tax profit (PTP)   118.6 114.4 315.3 502.5 426.1 385.5 0.0 0.0   Net earnings   92.3 64.3 215.6 446.9 332.0 300.5 0.0 0.0   Pre-tax profit without non-rec. items   119 114 315 502 426 385 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   345 229 134 43.8 19.3 9.8 0.0 0.0   Shareholders equity total   770 835 1,050 1,297 829 430 29.6 29.6   Interest-bearing liabilities   159 193 0.3 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,805 2,326 1,929 2,060 1,673 1,258 29.6 29.6   Net Debt   -73.4 -903 -462 -884 -1,060 -626 -29.6 -29.6     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,877 3,936 3,956 3,677 3,471 3,362 0.0 0.0   Gross profit growth   1.5% 1.5% 0.5% -7.1% -5.6% -3.1% -100.0% 0.0%   Employees   8 8 7 6 6 6 0 0   Employee growth %   14.3% 0.0% -12.5% -14.3% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,805 2,326 1,929 2,060 1,673 1,258 30 30   Balance sheet change%   -19.6% 28.9% -17.1% 6.8% -18.8% -24.8% -97.6% 0.0%   Added value   464.6 452.3 661.7 704.9 627.0 402.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -650 -641 -629 -380 -49 -19 -10 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   3.6% 3.2% 8.3% 14.0% 12.6% 11.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   6.9% 6.1% 15.4% 25.8% 23.4% 26.8% 0.0% 0.0%   ROI %   12.9% 11.3% 27.8% 43.9% 41.1% 62.4% 0.0% 0.0%   ROE %   12.8% 8.0% 22.9% 38.1% 31.2% 47.7% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   42.7% 35.9% 54.4% 63.0% 49.6% 34.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -15.8% -199.7% -69.8% -125.4% -229.7% -155.5% 0.0% 0.0%   Gearing %   20.7% 23.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   6.1% 6.9% 13.7% 8,292.4% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   1.0 1.4 1.8 2.5 1.8 1.4 0.0 0.0   Current Ratio   1.1 1.5 1.9 2.6 2.0 1.5 0.0 0.0   Cash and cash equivalent   232.6 1,096.1 462.3 883.7 1,060.4 625.5 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   69.2 594.6 816.5 1,253.3 809.8 419.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   58 57 95 117 105 67 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   58 57 95 117 77 67 0 0   EBIT / employee   17 16 47 86 73 65 0 0   Net earnings / employee   12 8 31 74 55 50 0 0